Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

Alaunos Therapeutics, Inc. (ZIOP) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/07/2021 GN Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting
02/05/2021 GN Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors
12/23/2020 GN Ziopharm to Participate in Upcoming January Conferences
12/21/2020 GN Ziopharm Oncology Announces Clearance of Taiwan's First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas
12/16/2020 GN Ziopharm Comments on Consent Solicitation Results
12/14/2020 GN Ziopharm Oncology Announces Chief Financial Officer to Step Down
12/11/2020 GN Ziopharm Comments on Delay of WaterMill's Stated Consent Deadline
12/10/2020 GN Egan-Jones Recommends Against Electing Dissident's Full Slate of Nominees to Ziopharm Board
12/04/2020 GN Ziopharm Details Actions in Response to Shareholder Feedback
11/27/2020 GN Ziopharm Comments on Institutional Shareholder Services' Recommendation to Reject WaterMill's Attempt to Remove Half of Ziopharm's Board of Directors
11/20/2020 GN Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Shareholder Value
11/19/2020 GN Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG at the 2020 Society for Neuro-Oncology Annual Meeting
11/17/2020 GN Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer
11/16/2020 GN Ziopharm Oncology Appoints Mary Thistle to Board of Directors
11/13/2020 GN Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020
11/02/2020 GN Ziopharm Files Definitive Consent Revocation Statement and Sends Letter to Shareholders
09/22/2020 GN Ziopharm Oncology Appoints Kevin Buchi to its Board of Directors
09/14/2020 GN Ziopharm Oncology Granted Rare Pediatric Disease Designation for Controlled IL-12 for the Treatment of DIPG
08/06/2020 GN Ziopharm Oncology Reports Second Quarter 2020 Financial Results and Provides Corporate Update
07/28/2020 GN Ziopharm Oncology to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020
07/22/2020 GN Ziopharm Oncology Names James Huang to Board of Directors
06/15/2020 GN Ziopharm Oncology Appoints Carl June, M.D., as Chairman of Scientific Advisory Board
06/12/2020 GN Ziopharm Oncology to Participate in Cell Therapy Panel at the Raymond James Human Healthcare Innovation Conference on June 17, 2020
05/27/2020 GN Ziopharm Oncology Announces Management Transition
05/27/2020 GN Ziopharm Oncology to Present at the Jefferies 2020 Healthcare Conference on June 3, 2020 
05/08/2020 GN Ziopharm Oncology to Present at the BofA Securities 2020 Health Care Conference
04/27/2020 GN Ziopharm Oncology to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 7, 2020
03/02/2020 GN Ziopharm Oncology Reports Financial Results for Fourth Quarter and Full Year 2019
02/24/2020 GN Ziopharm Oncology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Results on March 2, 2020
01/30/2020 GN Ziopharm Oncology Announces Recent Publications in Peer-Reviewed Scientific Journals
12/09/2019 GN Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12/08/2019 GN Ziopharm Oncology Presents Pre-Clinical Data Validating “Rapid Personalized Manufacture” (RPM) with TCR at the 2019 American Society for Hematology Annual Meeting
11/23/2019 GN Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting
11/18/2019 GN Ziopharm Oncology Updates Presentation and Webcast Time at the Jefferies 2019 London Healthcare Conference
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy